Drugs that target amyloid beta proteins in the brain likely have no clinically meaningful positive effects, while increasing ...

Most neurons that die in Alzheimer’s disease do not simply starve or get smothered by amyloid plaques. According to a study ...

The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein ...

Amyloid beta is a peptide that plays a central role in the neurodegenerative pathology of Alzheimer’s disease by aggregating into plaques in the brain. U.S. Food and Drug Administration (FDA) approved ...

Drugs designed to treat Alzheimer's disease by targeting amyloid proteins was seen in high amounts in patients' brains, but ...

The tiny protein known as transthyretin can cause big problems in the body when it misfolds after secretion. While healthy transthyretin moves hormones through blood and spinal fluid, misfolded ...

Coramitug is a potential best-in-class amyloid depleter antibody for the treatment of ATTR amyloidosis with cardiomyopathy1-3 Coramitug is being evaluated by Novo Nordisk in the ongoing Phase 3 ...

Weight loss and diabetes drugs may reduce brain damage linked to Alzheimer’s, but human studies show mixed results.

Here’s what you’ll learn when you read this story: The story of your life is encoded in your memories, but scientists don’t have a strong grasp on exactly how the brain turns a fleeting sensory ...